Biohaven Ltd.
BHVN
$30.40
-$0.57-1.84%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 42.17% | -28.74% | -33.21% | -39.67% | -52.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 100.48% | 116.55% | 123.80% | 19.75% | -6.06% |
| Operating Income | -100.48% | -116.55% | -123.80% | -19.75% | 6.06% |
| Income Before Tax | -106.49% | -68.09% | -70.30% | 5.58% | 28.13% |
| Income Tax Expenses | 153.15% | 96.33% | 61.75% | 70.18% | -415.75% |
| Earnings from Continuing Operations | -107.37% | -73.15% | -73.31% | 4.88% | 28.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -107.37% | -73.15% | -73.31% | 4.88% | 28.43% |
| EBIT | -100.48% | -116.55% | -123.80% | -19.75% | 6.06% |
| EBITDA | -101.88% | -117.67% | -124.54% | -19.00% | 7.27% |
| EPS Basic | -65.63% | -30.37% | -23.37% | 39.29% | 55.32% |
| Normalized Basic EPS | -60.22% | -66.65% | -60.82% | 25.52% | 44.71% |
| EPS Diluted | -65.63% | -30.37% | -23.37% | 39.29% | 55.32% |
| Normalized Diluted EPS | -60.22% | -66.65% | -60.82% | 25.52% | 44.71% |
| Average Basic Shares Outstanding | 28.13% | 29.47% | 34.30% | 43.58% | 59.24% |
| Average Diluted Shares Outstanding | 28.13% | 29.47% | 34.30% | 43.58% | 59.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
